Analysis of azithromycin in human plasma by LC-MS-MS


Yuezueak N., Oezden T., Eren S., Toptan S.

CHROMATOGRAPHIA, vol.66, 2007 (Journal Indexed in SCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 66
  • Publication Date: 2007
  • Doi Number: 10.1365/s10337-007-0294-7
  • Title of Journal : CHROMATOGRAPHIA

Abstract

A simple sensitive and selective liquid chromatographic-tandem mass spectrometric method was developed and validated for the quantification of azithromycin in human plasma. Roxithromycin was used as the internal standard. The chromatographic separation was performed on a SunFire C18, 50 mm x 2.1, 3.5 mu m column at 30 degrees C with mobile phase consisted of 1.54 g ammonium acetate, 250 mL water, 570 mL acetonitrile, 180 mL methanol and 0.6 mL glacial acetic acid. Flow rate was 0.2 mL min(-1). The work-up procedure involved a liquidliquid extraction of the compounds. Mass spectrometric data were acquired in single ion monitoring. MRM mode of the ions 749.58 > 591.6 and 837.64 > 158.2 for azithromycin and roxithromycin, respectively. The method was validated in the concentration range of 21,000 ng mL(-1). Absolute recovery of azithromycin was 81.97%. Retention time for azithromycin was 0.9 and 1.1 min for roxithromycin. The run time was 2 min. This method was found suitable to analyse human plasma samples for application in pharmacokinetic, pharmacodynamic, bioavailability/bioequivalance studies.